NeuroTech.com
Mind · Machine · Consciousness

The age of the
mind-machine
is here.

The future of consciousness, tracked daily.

Neurotechnology is rewriting what it means to be human — and what it means to be intelligent. We track the companies, breakthroughs, and ideas at this frontier, so you don't miss a moment of the most important shift in the history of mind.

"The question is no longer whether machines can think —but whether they can learn to love."

New

Shop neurotech products

EEG headsets, sleep wearables and brain stimulation devices you can buy today.

Browse products →

Browse by category

View all 787 companies →

Featured companies

View all →
K

Kernel

Research Tools

Featured

Kernel builds non-invasive neuroimaging helmets — the Flow (TD-fNIRS) and Flux (MEG) systems — designed to make high-resolution brain scanning accessible outside of hospital settings. Founded by Bryan Johnson, the company aims to democratize neuroscience research and brain measurement at scale.

Private · $53M+Visit →
M

MindMed

Psychedelics

Featured

MindMed is a clinical-stage psychedelic medicine company developing novel therapeutics derived from LSD, MDMA, and ibogaine analogs for neurological and psychiatric disorders. Their lead asset MM120 (LSD tartrate) has shown promising Phase 2b results for generalized anxiety disorder.

NASDAQ: MNMDVisit →

Recently added

Full directory →
CN

CortiSync Neuro

Brain-Computer Interfaces · Pittsburgh, PA

↗
MD

MindWave Diagnostics

Neurodiagnostics · Toronto, Ontario, Canada

↗
NB

Neurexo Biosciences

Neuropharmaceuticals · San Diego, CA

↗
NM

Nalu Medical

Neuromodulation · Carlsbad, California, USA

↗
N

Neurolutions

Brain-Computer Interfaces · St. Louis, Missouri, USA

↗
N

NeuroMetrix

Neurodiagnostics · Woburn, Massachusetts, USA

↗
PP

Praxis Precision Medicine

Neuropharmaceuticals · Cambridge, Massachusetts, USA

↗
SH

Sana Health

Neuromodulation · Louisville, Colorado, USA

↗
💰

Funding spotlight

🏢

CortiSync Neuro

Seed — $8M

🏢

MindWave Diagnostics

Series B — $61M

🏢

Neurexo Biosciences

Series A — $42M

🏢

Nalu Medical

Series D — approximately $175M raised

🏢

NeuroMetrix

Publicly traded — NASDAQ: NURO

🏢

Praxis Precision Medicine

Publicly traded — NASDAQ: PRAX

Latest news

All →
🧠Industry2026-10-19
Paradromics and Siemens Healthineers Launch Strategic Initiative to Build Advanced Imaging Foundation for BCIs

Paradromics and Siemens Healthineers are partnering to develop scalable advanced imaging infrastructure purpose-built for brain-computer interfaces.

🧠Industry2026-10-18
China's Neurotech Ambitions Signal a New Frontier in the Global Brain Race

The Economist flags China's accelerating push into neurotechnology, raising questions about competition, ethics, and global regulatory alignment.

🔬Research2026-10-17
Functional Ultrasound BCIs Cross a Threshold: From Brain Reading to Two-Way Control

Functional ultrasound brain-computer interfaces are advancing beyond passive decoding toward bidirectional control, marking a pivotal shift for the field.

🔬Research2026-10-16
Visual Cues Are Quietly Skewing BCI Accuracy Scores, and the Field Is Taking Notice

A new study finds visual cues artificially inflate deep learning accuracy metrics in brain-computer interfaces, raising urgent questions about benchmarking.

💰Funding2026-10-15
ReVision Implant Secures €4 Million to Advance Neural Vision Restoration Technology

ReVision Implant has closed a €4 million funding round to develop its neurotech implant platform targeting vision restoration.

🔬Research2026-10-14
NIH-Backed Device Gives People With Paralysis a New Path to Communication

A new device supported by the NIH is helping people with paralysis communicate, marking a meaningful step forward for assistive neurotechnology.

🔬Research2026-10-13
ABILITY Neurotech Begins Clinical Testing of Its Brain-Computer Interface System

ABILITY Neurotech has moved into active testing of its BCI technology, marking a significant milestone for the emerging company.

💰Funding2026-10-12
Flourish Emerges From Stealth With Bezos and Google Ventures Backing to Decode the Nervous System

Catalio-incubated neuroscience startup Flourish has launched with investment from Jeff Bezos and Google Ventures.

Every Sunday

The NeuroTech Digest

Funding rounds, breakthroughs, and top jobs — curated weekly for industry professionals.

Subscribe free →

For companies

Reach neurotech decision-makers

Premium listings, newsletter sponsorships, and featured placements.

View packages →

News & insights

All articles →

The field, by the numbers

787+

Companies mapped

across 9 sectors

$18B+

VC invested

in the field globally

3×/week

News published

Mon · Wed · Fri

99+

Articles

research & industry

Companies by sector

🧠

28

Brain-Computer

💭

15

Cognitive

💙

29

Mental

⚡

43

Neuromodulation

💊

38

Neuropharmaceuticals

🔬

27

Neurodiagnostics

🔭

11

Research

📊

13

Neurofeedback

🍄

39

Psychedelics

Every Sunday

The NeuroTech Digest

The signal through the noise — breakthroughs, funding, and ideas at the edge of mind and machine. Curated weekly.

No spam. Unsubscribe anytime.